Difficulty: Medium
Average Score: 92%
Practice
Indication for etidronate administration is:
Correct answer
B
Rationale
In pharmacology, etidronate is a bisphosphonate drug primarily used for the treatment of Paget's disease, making option B the correct answer. Paget's disease is a condition characterized by abnormal bone destruction and regrowth, leading to bone deformities and fractures. Etidronate helps regulate this process and reduce bone turnover in patients with Paget's disease.
Option A, malabsorption of vitamin D, is incorrect as etidronate is not indicated for this condition. Vitamin D deficiency in the diet (option C) is typically managed with vitamin D supplementation or dietary changes, not etidronate. Hypercalciuria (option D) involves excessive calcium excretion in the urine and is not a direct indication for etidronate use.
Educationally, understanding the specific indications for pharmacological agents is crucial for effective clinical decision-making. Knowing the appropriate use of etidronate in Paget's disease helps healthcare providers provide optimal care for patients. This question reinforces the importance of matching drug therapy to the correct clinical condition, improving patient outcomes and preventing medication errors.
Option A, malabsorption of vitamin D, is incorrect as etidronate is not indicated for this condition. Vitamin D deficiency in the diet (option C) is typically managed with vitamin D supplementation or dietary changes, not etidronate. Hypercalciuria (option D) involves excessive calcium excretion in the urine and is not a direct indication for etidronate use.
Educationally, understanding the specific indications for pharmacological agents is crucial for effective clinical decision-making. Knowing the appropriate use of etidronate in Paget's disease helps healthcare providers provide optimal care for patients. This question reinforces the importance of matching drug therapy to the correct clinical condition, improving patient outcomes and preventing medication errors.